Development of the Safe and Broad‐Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ‐AA Peptide Scaffold
Chemistry – A European Journal · 2023
DOI: 10.1002/chem.202300476 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry – A European Journal, 2023. Verfasst von Lei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of South Florida, 4202 E. Fowler Ave., Tampa, FL 33620, USA. Hauptthemen laut MEDLINE: COVID-19, Coronavirus OC43, Human. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
SARS‐CoV‐2 is still wreaking havoc all over the world with surging morbidity and high mortality. The main protease (M pro ) is essential in the replication of SARS‐CoV‐2, enabling itself an active target for antiviral development. Herein, we reported the design and synthesis of a new class of peptidomimetics‐constrained α, γ‐AA peptides, based on which a series of aldehyde and ketoamide inhibitors of the M pro of SARS‐CoV‐2 were prepared. The lead compounds showed excellent inhibitory activity in the FRET‐based M pro enzymatic assay not only for the M pro of SARS‐CoV‐2 but also for SARS‐CoV and MERS‐CoV, along with HCoVs like HCoV‐OC43, HCoV‐229E, HCoV‐NL63 and HKU1. The X‐ray crystallographic results demonstrated that our compounds form a covalent bond with the catalytic Cys145. They also demonstrated effective antiviral activity against live SARS‐CoV‐2. Overall, the results suggest that α, γ‐AA peptide could be a promising molecular scaffold in designing novel M pro inhibitors of SARS‐CoV‐2 and other coronaviruses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, University of South Florida, 4202 E. Fowler Ave., Tampa, FL 33620, USA.
- Department of Pharmacology and Toxicology, College of Pharmacy, University of Arizona, Tucson, Arizona, 85721, USA.
- Department of Molecular Medicine, Morsani College of Medicine, University of South Florida, 4202 E. Fowler Ave., Tampa, FL 33620, USA.
- Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, University of New Jersey, Piscataway, NJ, USA.
Förderung
- NIAID NIH HHS
- NIH HHS
- National Institutes of Health
Zitieren
APA
Wang, L., Ma, C., Sacco, M. D., Xue, S., Mahmoud, M., Calcul, L., Chen, Y., Wang, J., & Cai, J. (2023). Development of the Safe and Broad‐Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ‐AA Peptide Scaffold. Chemistry – A European Journal. https://doi.org/10.1002/chem.202300476
Vancouver
Wang L, Ma C, Sacco MD, Xue S, Mahmoud M, Calcul L, et al. Development of the Safe and Broad‐Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ‐AA Peptide Scaffold. Chemistry – A European Journal. 2023. doi:10.1002/chem.202300476
BibTeX
@article{Wang2023,
author = {Wang, Lei and Ma, Chunlong and Sacco, Michael Dominic and Xue, Songyi and Mahmoud, Mentalla and Calcul, Laurent and Chen, Yu and Wang, Jun and Cai, Jianfeng},
title = {Development of the Safe and Broad‐Spectrum Aldehyde and Ketoamide Mpro inhibitors Derived from the Constrained α, γ‐AA Peptide Scaffold},
journal = {Chemistry – A European Journal},
year = {2023},
doi = {10.1002/chem.202300476}
}
EUVIMED